스킵네비게이션

Enterprise Together with KSC

Company Overview
POCT system for diabetic control, incorporating pain-free (minimal pain) blood sampling device, whole-blood biosensor diagnostics system, and cloud data management system

Sectors

  • Medical and Health IT

Project Summary

  • Integrated POCT system for telemedicine

Business Model

  • Revenue model Production and sales of POCT and drug delivery deivces for remote medicine
  • Key Customer Individual users / Medical device companies
Major Performance

  • Investment

    • $570K (US Angels, Korea Venture Investment Co., Ltd)

  • Employees

    • 18(6)
    • 19(7)
    • 20(8)

  • Patent

    • US application: 4, Domestic application: 4
Overseas Expansion

Stage

Entering overseas markets

Status

US entity established, ongoing consulting with US health insurance companies, in preparation for market survey with US customers

Performance

Booth exhibition at ATTD 2020 (Madrid, Spain)

Products / Services
1 3
Target Country
USA
Date of Establishment
Sep 21, 2018
  • CEO
    Peter (Kyonghoon) Lee
  • Founder’s Background
    • Core Biosystems (USA), Founder & CEO (2015~2019)
    • NanoFacture (USA), Founder & CEO (2006~2015)
    • Ph.D.. in Chemistry and Biotechnology, University of Tokyo (1994~1999)
    • M.S., in Chemistry, Seoul National University (1990-1994)
    • B.S., in Chemistry, Seoul National University (1986-1990)
목록